Treatments for resectable pancreatic cancer

Last medical review:

The following are treatment options for resectable pancreatic cancer. Resectable means the tumour can be completely removed with surgery. Your healthcare team will suggest treatments based on your needs and work with you to develop a treatment plan.

Surgery

Surgery is the standard treatment for resectable pancreatic cancer. The type of surgery and amount of tissue that needs to be removed depends on several factors about the cancer, including the size of the tumour and where in the pancreas the tumour is located.

A Whipple procedure( also called a pancreaticoduodenectomy) is done to remove the head of the pancreas and surrounding structures. A Whipple procedure is used for resectable pancreatic cancer in the head of the pancreas.

A modified Whipple procedure( also called a pylorus-preserving pancreaticoduodenectomy) removes all the same tissues as the Whipple procedure except for the pylorus (the part of the stomach that connects to the small intestine). You may have a modified Whipple procedure for resectable pancreatic cancer in the head of the pancreas.

A distal pancreatectomy is done to remove the tail and part of the body of the pancreas as well as lymph nodes around the pancreas. It is used for resectable pancreatic cancer that is in the tail or body of the pancreas. The spleen is typically removed as well (called a splenectomy).

A total pancreatectomy removes all the same structures as the Whipple procedure but removes the entire pancreas instead of just the head. It is uncommon to have a total pancreatectomy. You will likely only have a total pancreatectomy in the rare case that the location of the tumour makes it impossible for the surgeon to remove it and preserve other parts of the pancreas.

Find out more about surgery for pancreatic cancer.

Chemotherapy

Chemotherapy uses drugs to destroy cancer cells. It may be offered following surgery for resectable pancreatic cancer to lower the chance that cancer will come back (called adjuvant chemotherapy).

In some cases, people with resectable pancreatic cancer who have very high levels of CA19-9 will also have chemotherapy before surgery to remove the tumour (called neoadjuvant chemotherapy).

Chemotherapy drug combinations used for resectable pancreatic cancer include:

  • FOLFIRINOX – irinotecan, oxaliplatin, fluorouracil (also called 5-fluorouracil or 5-FU) and leucovorin
  • gemcitabine and fluorouracil

If you cannot have these drug combinations, you may have fluorouracil or gemcitabine on their own.

Chemoradiation

Chemoradiation is chemotherapy and radiation therapy given during the same time period. You may be offered chemoradiation following surgery for resectable pancreatic cancer (called adjuvant chemoradiation) when there are cancer cells in the margin that was removed along with the tumour (called positive surgical margins). You may also have adjuvant chemotherapy after chemoradiation.

Chemoradiation is usually given with fluorouracil or gemcitabine.

Find out more about chemotherapy for pancreatic cancer.

Radiation therapy

Radiation therapy uses high-energy rays or particles to destroy cancer cells. You may have external radiation therapy as a part of chemoradiation after surgery for resectable pancreatic cancer.

Find out more about radiation therapy for pancreatic cancer.

Clinical trials

Talk to your doctor about clinical trials open to people with pancreatic cancer in Canada. Clinical trials look at new ways to prevent, find and treat cancer. Find out more about clinical trials.

Expert review and references

  • George Zogopoulos, MD, PhD, FRCSC, FACS
  • Steven Gallinger, MD, MSc, FRCSC
  • American Cancer Society. Treating Pancreatic Cancer, Based on Extent of the Cancer. 2024. https://www.cancer.org/.
  • Arnason T, Colwell B, Costa A, et al.. Guidelines for Adenocarcinoma of the Pancreas. Halifax, NS: Cancer Care Nova Scotia; 2020. https://www.nshealth.ca/cancer-care/.
  • Cancer Research UK. Surgery for Pancreatic Cancer. 2023. https://www.cancerresearchuk.org/.
  • Guideline Resource Unit (GURU). Adenocarcinoma of the Pancreas. Edmonton: Alberta Health Services; 2021: Clinical Practice Guideline GI-006 Version: 10. https://www.albertahealthservices.ca/info/cancerguidelines.aspx.
  • Hosni A, Elamir A, Knox J, McNamara M. Princess Margaret Cancer Center Clinical Practice Guidelines: Gastrointestinal, Pancreatic. University Health Network; 2019.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma Version 2.2024. 2024.
  • PDQ Adult Treatment Editorial Board. Pancreatic Cancer Treatment (PDQ®) – Patient Version. Bethesda, MD: National Cancer Institute; 2024. https://www.cancer.gov/.
  • Provincial Health Services Authority. BC Cancer Protocol Summary: Adjuvant Chemotherapy for Pancreatic Adenocarcinoma Using Gemcitabine. Vancouver, BC: 2022. https://www.bccancer.bc.ca/.
  • Provincial Health Services Authority. BC Cancer Protocol Summary: Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma using Capecitabine and Gemcitabine. Vancouver, BC: 2023. https://www.bccancer.bc.ca/.
  • Provincial Health Services Authority. BC Cancer Protocol Summary: Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma using Irinotecan, Oxaliplatin, Fluorouracil and Leucovorin. Vancouver, BC: 2023. https://www.bccancer.bc.ca/.
  • Tremblay A, Cook N, Gallinger S, Dhani N. University Health Network Guidelines for Management of Resectable, Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC). University Health Network; 2015.
  • Winter JM, Brody JR, Abrams RA, Posey JA, Yeo CJ. Cancer of the pancreas. DeVita VT Jr, Lawrence TS, Rosenberg S. eds. DeVita Hellman and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. Philadelphia, PA: Wolters Kluwer; 2023: Kindle version, chapter 55, https://read.amazon.ca/?asin=B0BG3DPT4Q&language=en-CA.

Your trusted source for accurate cancer information

With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society